[go: up one dir, main page]

FI980023L - Sienilääke, siihen soveltuva yhdiste, menetelmä niiden valmistamiseksi ja menetelmä niiden käyttämiseksi - Google Patents

Sienilääke, siihen soveltuva yhdiste, menetelmä niiden valmistamiseksi ja menetelmä niiden käyttämiseksi Download PDF

Info

Publication number
FI980023L
FI980023L FI980023A FI980023A FI980023L FI 980023 L FI980023 L FI 980023L FI 980023 A FI980023 A FI 980023A FI 980023 A FI980023 A FI 980023A FI 980023 L FI980023 L FI 980023L
Authority
FI
Finland
Prior art keywords
preparation
antifungal agent
compound suitable
suitable therefor
therefor
Prior art date
Application number
FI980023A
Other languages
English (en)
Swedish (sv)
Other versions
FI980023A0 (fi
FI119357B (fi
Inventor
Hiroki Kodama
Yoshimi Niwano
Kazuo Kanai
Masanori Yoshida
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of FI980023A0 publication Critical patent/FI980023A0/fi
Publication of FI980023L publication Critical patent/FI980023L/fi
Application granted granted Critical
Publication of FI119357B publication Critical patent/FI119357B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI980023A 1995-07-08 1998-01-07 Sienilääke, siihen soveltuva yhdiste ja menetelmä niiden valmistamiseksi FI119357B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP19617495 1995-07-08
JP19617495 1995-07-08
PCT/JP1996/001872 WO1997002821A2 (en) 1995-07-08 1996-07-05 Antifungal agent, compound therefor, process for producing the same
JP9601872 1996-07-05

Publications (3)

Publication Number Publication Date
FI980023A0 FI980023A0 (fi) 1998-01-07
FI980023L true FI980023L (fi) 1998-01-07
FI119357B FI119357B (fi) 2008-10-31

Family

ID=16353435

Family Applications (1)

Application Number Title Priority Date Filing Date
FI980023A FI119357B (fi) 1995-07-08 1998-01-07 Sienilääke, siihen soveltuva yhdiste ja menetelmä niiden valmistamiseksi

Country Status (21)

Country Link
US (1) US5900488A (fi)
EP (1) EP0839035B1 (fi)
KR (1) KR100386491B1 (fi)
CN (1) CN1091596C (fi)
AT (1) AT407832B (fi)
CA (1) CA2226214C (fi)
CH (1) CH692045A5 (fi)
DE (1) DE19681478B4 (fi)
DK (1) DK176599B1 (fi)
ES (1) ES2137888B1 (fi)
FI (1) FI119357B (fi)
GB (1) GB2317615B (fi)
IL (1) IL122618A (fi)
IN (1) IN185384B (fi)
LU (1) LU90190B1 (fi)
NO (1) NO980055L (fi)
NZ (1) NZ311796A (fi)
SE (1) SE9800016L (fi)
TW (1) TW450969B (fi)
WO (1) WO1997002821A2 (fi)
ZA (1) ZA965745B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127397A (en) * 1996-12-10 2000-10-03 Nihon Nohyaku Co., Ltd. Optically active (R)-(E)-(4-substituted-phenyl-1,3-dithiolan-2-ylidene)-1-imidazolylaceto nitrile derivative, antifungal composition comprising the same, and method for producing the same
WO2003105903A1 (ja) * 2002-06-18 2003-12-24 ポーラ化成工業株式会社 抗真菌医薬組成物
US8039452B2 (en) * 2002-06-18 2011-10-18 Pola Pharma Inc. Antifungal medicinal compositions
EP2025337B1 (en) * 2006-03-08 2014-09-10 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
RU2423128C2 (ru) * 2006-03-08 2011-07-10 Нихон Нохияку Ко., Лтд. Фармацевтическая композиция для наружного применения
CA2645110C (en) * 2006-03-08 2013-11-19 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
JP5313905B2 (ja) * 2007-08-27 2013-10-09 日本農薬株式会社 真菌性皮膚炎用剤
WO2009031644A1 (ja) 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌医薬組成物
WO2009031642A1 (ja) 2007-09-05 2009-03-12 Pola Pharma Inc. 医薬組成物
CN101808638B (zh) 2007-09-05 2012-07-25 宝丽制药股份有限公司 抗真菌组合物
WO2010093992A1 (en) * 2009-02-13 2010-08-19 Topica Pharmaceuticals, Inc Anti-fungal formulation
WO2010117089A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
US9050271B2 (en) 2009-04-09 2015-06-09 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN102481286B (zh) * 2009-08-25 2014-02-26 宝丽制药股份有限公司 抗真菌药物组合物
US8962669B2 (en) 2010-06-11 2015-02-24 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN103012385B (zh) * 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
JP5589130B1 (ja) * 2012-09-14 2014-09-10 株式会社ポーラファルマ 結晶及び該結晶を含有してなる医薬製剤
WO2014041846A1 (en) * 2012-09-14 2014-03-20 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal
US9199977B2 (en) * 2012-09-14 2015-12-01 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
EP2948146A1 (en) * 2013-01-28 2015-12-02 Pola Pharma Inc. Pharmaceutical composition for diseases caused by pathogenic microorganisms such as candida
WO2014115487A1 (en) * 2013-01-28 2014-07-31 Pola Pharma Inc. Pharmaceutical composition for diseases caused by pathogenic microorganisms such as aspergillus
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) * 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
AR100180A1 (es) * 2014-04-25 2016-09-14 Syngenta Participations Ag Derivados de imidazol microbiocidas
US10703744B2 (en) 2014-12-12 2020-07-07 Glenmark Life Sciences Limited Process for preparation of luliconazole
WO2017108972A1 (en) 2015-12-21 2017-06-29 Laboratorios Lesvi, S.L. Compounds of r-(-)-(e)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1 -imidazolylacetonitrile-ha (luliconazole-ha) as antifungals
CN106008166B (zh) * 2016-05-17 2018-09-25 上海福乐医药科技有限公司 一种手性2-氯-1-(2,4-二氯苯基)乙醇的工业化生产方法
EP3558304A2 (en) 2016-12-23 2019-10-30 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Inhibitors of cytochrome p450 family 7 subfamily b member 1 (cyp7b1) for use in treating diseases
TR201714882A2 (tr) 2017-10-03 2019-04-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
US10898470B1 (en) 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
WO2023131969A1 (en) * 2022-01-09 2023-07-13 Kimia Biosciences Limited Improved process for the preparation of luliconazole

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587252T2 (de) * 1985-10-09 1993-07-15 Nihon Nohyaku Co Ltd Keten-s,s,-acetalderivate, verfahren zu ihrer herstellung und methode zur heilung von mykose unter verwendung dieser derivate.
EP0218736B1 (en) * 1985-10-10 1993-04-07 Nihon Nohyaku Co., Ltd. A ketene s,s-acetal derivative, a process for manufacturing thereof and a method for curing mycosis by administering it
JP3030780B2 (ja) * 1988-12-29 2000-04-10 日本農薬株式会社 光学活性なケテンジチオアセタール誘導体及びその製造方法
JPH0386337A (ja) * 1989-08-28 1991-04-11 Maeda Seisakusho:Kk エクスパンディングチャックを用いた多重巻締め機および多重巻締め方法
CN1038247C (zh) * 1990-05-16 1998-05-06 云南省建筑材料科学研究设计院 一种新型磷石膏胶结料
JP3038519B2 (ja) * 1992-01-28 2000-05-08 日本農薬株式会社 創傷治癒促進剤

Also Published As

Publication number Publication date
MX9710401A (es) 1998-07-31
GB2317615A (en) 1998-04-01
FI980023A0 (fi) 1998-01-07
ATA906196A (de) 2000-11-15
GB9726766D0 (en) 1998-02-18
ES2137888A1 (es) 1999-12-16
DK176599B1 (da) 2008-10-27
AU6319296A (en) 1997-02-10
FI119357B (fi) 2008-10-31
CN1194582A (zh) 1998-09-30
AT407832B (de) 2001-06-25
TW450969B (en) 2001-08-21
WO1997002821A2 (en) 1997-01-30
ZA965745B (en) 1997-01-27
DE19681478T1 (de) 1998-07-02
HK1009751A1 (en) 1999-06-11
KR100386491B1 (ko) 2003-08-21
CH692045A5 (de) 2002-01-15
WO1997002821A3 (en) 1997-02-20
SE9800016D0 (sv) 1998-01-07
DE19681478B4 (de) 2006-09-21
KR19990028772A (ko) 1999-04-15
EP0839035B1 (en) 2002-10-02
IL122618A (en) 2002-07-25
SE9800016L (sv) 1998-01-07
NO980055D0 (no) 1998-01-06
IL122618A0 (en) 1998-08-16
US5900488A (en) 1999-05-04
GB2317615B (en) 1998-09-02
LU90190B1 (de) 1998-03-02
CA2226214C (en) 2007-04-17
DK1398A (da) 1998-01-07
CN1091596C (zh) 2002-10-02
NZ311796A (en) 1999-06-29
AU697571B2 (en) 1998-10-08
ES2137888B1 (es) 2001-01-01
CA2226214A1 (en) 1997-01-30
NO980055L (no) 1998-03-06
EP0839035A2 (en) 1998-05-06
IN185384B (fi) 2001-01-13

Similar Documents

Publication Publication Date Title
FI980023L (fi) Sienilääke, siihen soveltuva yhdiste, menetelmä niiden valmistamiseksi ja menetelmä niiden käyttämiseksi
FI962917A7 (fi) Mikrokapselit, menetelmä niiden valmistamiseksi, ja niiden käyttö
FI973426L (fi) Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi
FI951468A7 (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
FI960751A7 (fi) Substituoidut atsaindolylideeniyhdisteet ja menetelmä niiden valmistamiseksi
FI965020A7 (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
FI972164L (fi) Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö
FI972165A7 (fi) Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö
FI962927A7 (fi) Tetrasykliinijohdannaisia, valmistusmenetelmä ja käyttö
FI960889A7 (fi) Naftyyliyhdisteitä, välituotteita, koostumuksia ja menetelmiä
NO950425L (no) Antifungale midler, fremgangsmåter for fremstilling av disse, og mellomprodukter
FI970808L (fi) Aerogeeliä sisältäviä komposiittimateriaaleja, menetelmä niiden valmistamiseksi ja niiden käyttö
FI973522A7 (fi) Vesipitoisia, lesitiinipohjaisia irrotteita ja menetelmät niiden käytt ämiseksi
CY2013003I1 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
FI944417L (fi) Atsoliyhdisteet, niiden valmistus ja käyttö
FI922875A7 (fi) Reniiniä estävät yhdisteet, menetelmä niiden valmistamiseksi ja niidenkäyttö
FI915381A7 (fi) Substituoituja atsoleja, menetelmä niiden valmistamiseksi ja niiden käyttö
EE04346B1 (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
FI970997L (fi) Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö
FI944182A7 (fi) Yhtenäiskiteitä sisältävä koostumus, menetelmä sen valmistamiseksi ja sen käyttö
FI951631L (fi) Substituoituja kynureniinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI953173L (fi) Orto-aminosubstituoituja bentsolyyliguanidiinejä, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine
FI941914A0 (fi) 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö
FI964229L (fi) Menetelmä doksorubisiinin valmistamiseksi
FI953532L (fi) Nitroglyserolia sisältävä laastari, menetelmä sen valmistamiseksi ja sen käyttö

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119357

Country of ref document: FI

MA Patent expired